Associate Professor Teresa Lambe is a Principal Investigator at the Jenner Institute,University of Oxford. Prof Lambe has been involved in immunology research for over fifteen years with extensive knowledge in the assessment of naturally acquired and post-vaccination immune responses. 

Professor Lambe’s research programme focuses on developing innovative vaccines against emerging and outbreak pathogens. Outside of her most recent work on the ChAdOx1 nCoV-19 (AZD1222) vaccine, her group have progressed novel vaccine development against lethal haemorrhagic viral diseases such as Ebolavirus, Lassa fever virus and Crimean-Congo haemorrhagic fever. This experience proved to be a dry-run for her recent work developing a vaccine against SARS-CoV-2. As well as her role in the initial design of the ChAdOx1 nCoV-19 vaccine and leading the pre-clinical testing programme, Professor Lambe’s group are leading critical laboratory studies evaluating the antibody response post-vaccination.